{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:14:06Z","timestamp":1770434046884,"version":"3.49.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1097\/mop.0b013e3283464a52","type":"journal-article","created":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T05:45:08Z","timestamp":1302241508000},"page":"298-304","source":"Crossref","is-referenced-by-count":41,"title":["Recent progress in understanding pediatric pulmonary hypertension"],"prefix":"10.1097","volume":"23","author":[{"given":"Steven H","family":"Abman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D Dunbar","family":"Ivy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210206","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ppedcard.2009.09.002","article-title":"Towards improving care of children with pulmonary hypertension: the rationale for developing a Pediatric Pulmonary Hypertension Network","volume":"27","author":"Abman","year":"2009","journal-title":"Prog Pediatr Cardiol"},{"key":"R2-8-20210206","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension: results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"R3-8-20210206","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.0000029100.82385.58","article-title":"Survival in primary pulmonary hypertension: the impact of epoprostenol therapy","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation"},{"issue":"Suppl","key":"R4-8-20210206","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R5-8-20210206","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2009.04.013","article-title":"The 4th World Symposium on Pulmonary Hypertension","volume":"54","author":"Humbert","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R6-8-20210206","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simmoneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R7-8-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/09031936.00056110","article-title":"Pulmonary arterial hypertension: a comparison between children and adults","volume":"37","author":"Barst","year":"2011","journal-title":"Eur Respir J"},{"key":"R8-8-20210206","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jpeds.2009.02.036","article-title":"Clinical characterization of pediatric pulmonary hypertension: complex presentation and diagnosis","volume":"155","author":"Van Loon","year":"2009","journal-title":"J Pediatr"},{"key":"R9-8-20210206","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.amjcard.2010.02.023","article-title":"Outcome of pediatric patients with pulmonary artery hypertension","volume":"106","author":"Van Loon","year":"2010","journal-title":"Am J Cardiol"},{"key":"R10-8-20210206","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.acvd.2009.12.001","article-title":"Characteristics and prospective 2 year follow-up of children with pulmonary arterial hypertension in France","volume":"103","author":"Fraisse","year":"2010","journal-title":"Arch Cardiovasc Dis"},{"key":"R11-8-20210206","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jacc.2009.04.009","article-title":"Development and pathology of pulmonary hypertension","volume":"54","author":"Tuder","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R12-8-20210206","doi-asserted-by":"crossref","first-page":"L600","DOI":"10.1152\/ajplung.2000.279.3.L600","article-title":"Inhibition of angiogenesis decreases alveolarization in the developing rat lung","volume":"279","author":"Jakkula","year":"2000","journal-title":"Am J Physiol LCMP"},{"key":"R13-8-20210206","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.physiol.67.040403.102229","article-title":"Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia","volume":"67","author":"Stenmark","year":"2005","journal-title":"Ann Rev Physiol"},{"key":"R14-8-20210206","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ydbio.2007.04.042","article-title":"Epithelial vascular cross talk mediated by VEGF and HGF signaling directs primary septae formation during distal lung morphogenesis","volume":"308","author":"Yamamoto","year":"2007","journal-title":"Dev Biol"},{"key":"R15-8-20210206","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-1-60761-500-2_21","article-title":"Impaired VEGF signaling in the pathogenesis of neonatal pulmonary vascular disease","volume":"661","author":"Abman","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"R16-8-20210206","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-60761-500-2_13","article-title":"Developmental regulation of oxygen sensing and ion channels in the pulmonary vasculature","volume":"661","author":"Cornfield","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"R17-8-20210206","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1164\/rccm.201006-0869WS","article-title":"Strategic plan for lung vascular research: an NHLBI-ORDR workshop report","volume":"182","author":"Erzurum","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R18-8-20210206","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1161\/CIRCULATIONAHA.109.916098","article-title":"Epigenetic alteration of mitochondrial SOD2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target","volume":"121","author":"Archer","year":"2010","journal-title":"Circulation"},{"key":"R19-8-20210206","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.healun.2008.02.009","article-title":"Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension","volume":"27","author":"Rosenzweig","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R20-8-20210206","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ahj.2007.06.003","article-title":"Long term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?","volume":"154","author":"Van Loon","year":"2007","journal-title":"Am Heart J"},{"key":"R21-8-20210206","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/hrt.2008.150086","article-title":"Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001\u20132006","volume":"95","author":"Haworth","year":"2009","journal-title":"Heart"},{"key":"R22-8-20210206","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ppedcard.2009.09.004","article-title":"Noncongenital heart disease associated pediatric pulmonary arterial hypertension","volume":"27","author":"Ivy","year":"2009","journal-title":"Prog Pediatr Cardiol"},{"key":"R23-8-20210206","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ppedcard.2009.09.007","article-title":"Pulmonary hypertension in bronchopulmonary dysplasia","volume":"27","author":"Mourani","year":"2009","journal-title":"Prog Pediatr Cardiol"},{"key":"R25-8-20210206","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2141.2010.08097.x","article-title":"Exercise capacity and hemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies","volume":"149","author":"Barst","year":"2010","journal-title":"Br J Haematol"},{"key":"R26-8-20210206","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjcard.2009.04.034","article-title":"Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease","volume":"104","author":"Dham","year":"2009","journal-title":"Am J Cardiol"},{"key":"R27-8-20210206","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1172\/JCI33452","article-title":"Molecular pathogenesis of pulmonary arterial hypertension","volume":"118","author":"Rabinovitch","year":"2008","journal-title":"J Clin Invest"},{"key":"R28-8-20210206","first-page":"275","article-title":"Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension","volume":"144","author":"Tuder","year":"1994","journal-title":"Am J Pathol"},{"key":"R29-8-20210206","doi-asserted-by":"crossref","first-page":"L555","DOI":"10.1152\/ajplung.00408.2001","article-title":"Brief neonatal treatment with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure in adult rats","volume":"283","author":"Le Cras","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Biol"},{"key":"R30-8-20210206","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1164\/rccm.200812-1949OC","article-title":"Circulating endothelial progenitor cells in preterm infants with BPD","volume":"180","author":"Borghesi","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R31-8-20210206","first-page":"L1073","article-title":"Hyperoxia reduces bone marrow, circulating and lung endothelial progenitor cells: implications for the pathogenesis of bronchopulmonary dysplasia","volume":"292","author":"Balasubramaniam","year":"2007","journal-title":"Am J Physiol"},{"key":"R32-8-20210206","first-page":"L315","article-title":"Bone marrow derived angiogenic cells restore alveolar and vascular structure after neonatal hyperoxia in infant mice","volume":"298","author":"Balasubramaniam","year":"2010","journal-title":"Am J Physiol"},{"key":"R33-8-20210206","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/CIRCULATIONAHA.108.808246","article-title":"Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease","volume":"119","author":"Smajda","year":"2009","journal-title":"Circulation"},{"key":"R34-8-20210206","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10456-010-9192-y","article-title":"Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension.","volume":"14","author":"Smajda","year":"2011","journal-title":"Angiogenesis"},{"key":"R35-8-20210206","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.amjcard.2010.03.048","article-title":"Usefulness of the right ventricular systolic to diastolic duration ratio to predict functional capacity and survival in children with pulmonary arterial hypertension","volume":"106","author":"Alkon","year":"2010","journal-title":"Am J Cardiol"},{"key":"R36-8-20210206","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.amjcard.2009.12.075","article-title":"Effectiveness of transition from intravenous epoprostenol to oral\/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension","volume":"105","author":"Melnick","year":"2010","journal-title":"Am J Cardiol"},{"key":"R37-8-20210206","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00246-010-9645-5","article-title":"Vasodilator testing with NO and or oxygen in pediatric pulmonary hypertension","volume":"31","author":"Barst","year":"2010","journal-title":"Pediatr Cardiol"},{"key":"R38-8-20210206","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1542\/peds.2007-1583","article-title":"Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease","volume":"121","author":"Mourani","year":"2008","journal-title":"Pediatrics"},{"key":"R39-8-20210206","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.earlhumdev.2010.01.030","article-title":"Functional echocardiography: from physiology to treatment","volume":"86","author":"De Waal","year":"2010","journal-title":"Early Hum Dev"},{"key":"R40-8-20210206","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/adc.2009.169904","article-title":"Comparison of 6 min walk test distance and cardiopulmonary exercise test performance in children with pulmonary hypertension.","volume":"96","author":"Lammers","year":"2011","journal-title":"Arch Dis Child"},{"key":"R41-8-20210206","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-148-4-200802190-00006","article-title":"The enigma of pulmonary arterial hypertension: new insights from genetic studies","volume":"148","author":"Newman","year":"2008","journal-title":"Ann Int Med"},{"key":"R42-8-20210206","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/rccm.200712-1807OC","article-title":"Clinical outcomes of pulmonary artery hypertension in carriers of BMPR2 mutation","volume":"177","author":"Sztrymf","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R43-8-20210206","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1203\/01.PDR.0000139481.20847.D0","article-title":"Primary pulmonary hypertension in children may have a different genetic background than adults","volume":"56","author":"Grunig","year":"2004","journal-title":"Pediatr Res"},{"key":"R44-8-20210206","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.CIR.0000153798.78540.87","article-title":"Transforming growth factor \u03b2 receptor mutations and pulmonary arterial hypertension in childhood","volume":"111","author":"Harrison","year":"2005","journal-title":"Circulation"},{"key":"R45-8-20210206","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jpeds.2010.06.010","article-title":"Medical therapy for pediatric pulmonary arterial hypertension","volume":"157","author":"Tissot","year":"2010","journal-title":"J Pediatr"},{"key":"R46-8-20210206","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1742-1241.2010.02525.x","article-title":"How has epoprostenol changed the outcome for patients with pulmonary arterial hypertension?","volume":"168","author":"Barst","year":"2010","journal-title":"Int J Clin Pract Suppl"},{"key":"R47-8-20210206","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.0000138104.83366.E9","article-title":"Outcomes in children with IPAH","volume":"110","author":"Yung","year":"2004","journal-title":"Circulation"},{"issue":"Suppl 160","key":"R48-8-20210206","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1742-1241.2008.01811.x","article-title":"Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension.","volume":"62","author":"Doran","year":"2008","journal-title":"Int J Clin Pract"},{"key":"R49-8-20210206","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1086\/605320","article-title":"Closed-Hub systems with protected connections reduce risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension","volume":"30","author":"Ivy","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R50-8-20210206","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2007.09.031","article-title":"Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension","volume":"51","author":"Ivy","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R51-8-20210206","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.amjcard.2006.09.119","article-title":"Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil","volume":"99","author":"Ivy","year":"2007","journal-title":"Am J Cardiol"},{"key":"R52-8-20210206","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jpeds.2010.09.025","article-title":"Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension.","volume":"158","author":"Levy","year":"2011","journal-title":"J Pediatr"},{"key":"R53-8-20210206","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2005.01.066","article-title":"Effects of long-term bosentan in children with pulmonary arterial hypertension","volume":"46","author":"Rosenzweig","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R54-8-20210206","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.amjcard.2010.06.064","article-title":"Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings","volume":"106","author":"Ivy","year":"2010","journal-title":"Am J Cardiol"},{"key":"R55-8-20210206","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jpeds.2008.09.021","article-title":"Effects of long term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease","volume":"154","author":"Mourani","year":"2009","journal-title":"J Pediatr"},{"key":"R56-8-20210206","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1161\/CIRCULATIONAHA.104.473371","article-title":"Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study","volume":"111","author":"Humpl","year":"2005","journal-title":"Circulation"},{"key":"R57-8-20210206","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/CIRCULATIONAHA.106.655266","article-title":"PDE5 is highly expressed in the hypertrophied human right ventricle and acute inhibition of PDE5 improves contractility","volume":"116","author":"Nagendran","year":"2007","journal-title":"Circulation"},{"key":"R58-8-20210206","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-010-2065-4","article-title":"Intravenous sildenafil for postoperative pulmonary hypertension in children with pulmonary hypertension.","volume":"37","author":"Fraisse","year":"2011","journal-title":"Int Care Med"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0b013e3283464a52","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:40:53Z","timestamp":1620963653000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201106000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e3283464a52","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}